These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36822216)

  • 1. Protein kinases: Role of their dysregulation in carcinogenesis, identification and inhibition.
    Sarkar N; Singh A; Kumar P; Kaushik M
    Drug Res (Stuttg); 2023 Apr; 73(4):189-199. PubMed ID: 36822216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of FDA-approved small molecule protein kinase inhibitors.
    Roskoski R
    Pharmacol Res; 2019 Jun; 144():19-50. PubMed ID: 30877063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human kinome and kinase inhibition.
    Duong-Ly KC; Peterson JR
    Curr Protoc Pharmacol; 2013 Mar; Chapter 2():Unit2.9. PubMed ID: 23456613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase inhibitors: contributions from structure to clinical compounds.
    Johnson LN
    Q Rev Biophys; 2009 Feb; 42(1):1-40. PubMed ID: 19296866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structural atlas of kinases inhibited by clinically approved drugs.
    Wang Q; Zorn JA; Kuriyan J
    Methods Enzymol; 2014; 548():23-67. PubMed ID: 25399641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update.
    Roskoski R
    Pharmacol Res; 2021 Mar; 165():105463. PubMed ID: 33513356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of targeting protein kinases in cancer therapeutics.
    Tsai CJ; Nussinov R
    Semin Cancer Biol; 2013 Aug; 23(4):235-42. PubMed ID: 23651790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review of protein kinase inhibitors for cancer therapy.
    Kannaiyan R; Mahadevan D
    Expert Rev Anticancer Ther; 2018 Dec; 18(12):1249-1270. PubMed ID: 30259761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence and utility of intrinsically disordered regions in kinases.
    Kathiriya JJ; Pathak RR; Clayman E; Xue B; Uversky VN; Davé V
    Mol Biosyst; 2014 Nov; 10(11):2876-88. PubMed ID: 25099472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery.
    Volkamer A; Eid S; Turk S; Jaeger S; Rippmann F; Fulle S
    J Chem Inf Model; 2015 Mar; 55(3):538-49. PubMed ID: 25557645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dynamic nature of the kinome.
    Graves LM; Duncan JS; Whittle MC; Johnson GL
    Biochem J; 2013 Feb; 450(1):1-8. PubMed ID: 23343193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 update.
    Roskoski R
    Pharmacol Res; 2022 Jan; 175():106037. PubMed ID: 34921994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25 years of small molecular weight kinase inhibitors: potentials and limitations.
    Fabbro D
    Mol Pharmacol; 2015 May; 87(5):766-75. PubMed ID: 25549667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinases as drug targets.
    Yli-Kauhaluoma J; Tuominen RK
    Curr Top Med Chem; 2011; 11(11):1304. PubMed ID: 21513501
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances of small molecule targeting of kinases.
    Berndt N; Karim RM; Schönbrunn E
    Curr Opin Chem Biol; 2017 Aug; 39():126-132. PubMed ID: 28732278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors.
    Sharma S; Singh J; Ojha R; Singh H; Kaur M; Bedi PMS; Nepali K
    Eur J Med Chem; 2016 Apr; 112():298-346. PubMed ID: 26907156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale proteomics analysis of the human kinome.
    Oppermann FS; Gnad F; Olsen JV; Hornberger R; Greff Z; Kéri G; Mann M; Daub H
    Mol Cell Proteomics; 2009 Jul; 8(7):1751-64. PubMed ID: 19369195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A historical overview of protein kinases and their targeted small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Kinase Interaction Networks: A New Paradigm in PPI Based Design of Kinase Inhibitors.
    Jenardhanan P; Panneerselvam M; Mathur PP
    Curr Top Med Chem; 2019; 19(6):467-485. PubMed ID: 31184298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.